Nutritional Intervention With the Dietary Supplement, Immunocal® in MCI Patients: Promotion of Brain Health
Not Applicable
- Conditions
- Mild Cognitive Impairment (MCI)
- Interventions
- Dietary Supplement: Immunocal
- First Posted Date
- 2018-02-27
- Last Posted Date
- 2021-02-10
- Lead Sponsor
- Immunotec Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT03448055
- Locations
- 🇨🇦
Memory Clinic/Jewish General Hospital, Montréal, Quebec, Canada
Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients
Phase 3
Terminated
- Conditions
- NON-SMALL CELL LUNG CANCER
- Interventions
- Dietary Supplement: CaseinDietary Supplement: IMN1207
- First Posted Date
- 2010-01-12
- Last Posted Date
- 2015-01-21
- Lead Sponsor
- Immunotec Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT01046383
- Locations
- 🇨🇦
Juravinski Cancer Centre, Hamilton, Ontario, Canada
🇨🇦CHUM - Hopital Notre Dame, Montreal, Quebec, Canada
🇨🇦British Columbia Cancer Agency, Vancouver, British Columbia, Canada
Effect of Immunocal® With Exercise Versus Casein With Exercise on Aging Processes in Elderly Persons
Phase 2
Completed
- Conditions
- SarcopeniaAging
- Interventions
- Dietary Supplement: ImmunocalDietary Supplement: Casein
- First Posted Date
- 2009-07-09
- Last Posted Date
- 2021-02-09
- Lead Sponsor
- Immunotec Inc.
- Target Recruit Count
- 99
- Registration Number
- NCT00935610
- Locations
- 🇨🇦
Institut de recherches cliniques de Montréal, Montreal, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath